Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Currie

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
Aquatic Ecosystem Health & Management|May 6, 2026
Stable isotopes reveal an imprint of harmful algal blooms on Lake ErieK C Benesh, A Banerji, S A Ludsin, et al.
Current Biology : CB|March 5, 2013
Evolution of mir-92a underlies natural morphological variation in Drosophila melanogasterSaad Arif, Sophie Murat, Isabel Almudi, et al.
Cloning and Stem Cells|May 16, 2008
The inhibitory role of stromal cell mesenchyme on human embryonic stem cell hepatocyte differentiation is overcome by Wnt3a treatmentJudy Fletcher, Wei Cui, Kay Samuel, et al.
BMC Rheumatology|March 30, 2021
Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritisChristopher W Pohlmeyer, Ching Shang, Pei Han, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agentA W Alberts, J Chen, G Kuron, et al.
Journal of Medicinal Chemistry|May 1, 2014
Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinaseKevin S Currie, Jeffrey E Kropf, Tony Lee, et al.
Journal of Medicinal Chemistry|February 3, 2015
Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2Kurt G Pike, Jeff Morris, Linette Ruston, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2008
Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signalingDavid C Hay, Judy Fletcher, Catherine Payne, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2009
Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4Scott A Mitchell, Mihaela Diana Danca, Peter A Blomgren, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Discovery, synthesis and biological evaluation of novel glucokinase activatorsDarren McKerrecher, Joanne V Allen, Suzanne S Bowker, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Aquatic Ecosystem Health & Management|May 6, 2026
Stable isotopes reveal an imprint of harmful algal blooms on Lake ErieK C Benesh, A Banerji, S A Ludsin, et al.
Current Biology : CB|March 5, 2013
Evolution of mir-92a underlies natural morphological variation in Drosophila melanogasterSaad Arif, Sophie Murat, Isabel Almudi, et al.
Cloning and Stem Cells|May 16, 2008
The inhibitory role of stromal cell mesenchyme on human embryonic stem cell hepatocyte differentiation is overcome by Wnt3a treatmentJudy Fletcher, Wei Cui, Kay Samuel, et al.
BMC Rheumatology|March 30, 2021
Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritisChristopher W Pohlmeyer, Ching Shang, Pei Han, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agentA W Alberts, J Chen, G Kuron, et al.
Journal of Medicinal Chemistry|May 1, 2014
Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinaseKevin S Currie, Jeffrey E Kropf, Tony Lee, et al.
Journal of Medicinal Chemistry|February 3, 2015
Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2Kurt G Pike, Jeff Morris, Linette Ruston, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2008
Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signalingDavid C Hay, Judy Fletcher, Catherine Payne, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2009
Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4Scott A Mitchell, Mihaela Diana Danca, Peter A Blomgren, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Discovery, synthesis and biological evaluation of novel glucokinase activatorsDarren McKerrecher, Joanne V Allen, Suzanne S Bowker, et al.
Pageof 21